1.
Hanžel J, Košir Božič T, Janša R. Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world study. RO [Internet]. 2020May31 [cited 2021Sep.18];54(2):233-6. Available from: https://www.radioloncol.com/index.php/ro/article/view/3362